HLA polymorphisms as incidence factor in the progression to end-stage renal disease in Brazilian patients awaiting kidney transplant

被引:26
作者
Crispim, J. C. [1 ]
Mendes-Junior, C. T. [2 ]
Wastowski, I. J. [1 ]
Palomino, G. Martelli [1 ]
Saber, L. T.
Rassi, D. M. [2 ]
Donadi, E. A. [2 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Div Clin Immunol, BR-14049900 Ribeirao Preto, Brazil
关键词
D O I
10.1016/j.transproceed.2008.02.086
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic renal failure (CRF) leads in the majority of instances to end-stage renal disease (ESRD) requiring renal replacement therapy. Age, gender, genetics, race, hypertension, and smoking among others are factors associated with ESRD. Our interest was to evaluate the possible associations of class I and II HLA antigens with ESRD renal disease independent of other factors, among patients with CRF, having various diagnoses in the Brazilian population of the Sao Paulo state. So 21 HLA-A, 31 HLA-B, and 13 HLA-DR were detected in 105 patients who were compared with 160 healthy controls of both sexes who were not related to the patients evaluated until 2005. We calculated allelic frequencies, haplotypes frequencies, etiological fractions (EF), preventive fractions, and relative risks (RR). We compared demographic data of patients and controls. The antigens positively associated with ESRD were: HLA-A78 (RR = 30.31 and EF = 0.96) and HLA-DR11 (RR = 18.87 and EF = 0.65). The antigens HLAB14 (RR = 29.90 and EF = 0.75) was present at a significantly lower frequency among patients compared with controls. In contrast, no haplotype frequency showed statically significant associations. Further molecular studies may clarify types and subtypes of alleles involved with ESRD progression.
引用
收藏
页码:1333 / 1336
页数:4
相关论文
共 9 条
[1]   Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure [J].
Doxiadis, IIN ;
de Lange, P ;
de Vries, E ;
Persijn, GG ;
Claas, FHJ .
TISSUE ANTIGENS, 2001, 57 (04) :344-347
[2]   Comparative study of HLA-DR typing by serology and sequence-specific primer analysis in a genetically highly diverse population of kidney transplant recipients [J].
Ferraz, AS ;
Saber, LS ;
Voltarelli, JC ;
Mytilineos, J ;
Opelz, G ;
Donadi, EA .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (02) :463-465
[3]   IGA NEPHROPATHY - ANALYSIS OF THE NATURAL-HISTORY, IMPORTANT FACTORS IN THE PROGRESSION OF RENAL-DISEASE, AND A REVIEW OF THE LITERATURE [J].
IBELS, LS ;
GYORY, AZ .
MEDICINE, 1994, 73 (02) :79-102
[4]  
LOUZADA P, 2001, TISSUE ANTIGENS, V125, P320
[5]  
MORAES MEH, 2001, TISSUE ANTIGENS, V114, P235
[6]   MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data [J].
Papassavas, EC ;
Spyropoulou-Vlachou, M ;
Papassavas, AC ;
Schipper, RF ;
Doxiadis, IN ;
Stavropoulos-Giokas, C .
HUMAN IMMUNOLOGY, 2000, 61 (06) :615-623
[7]   The probability of finding a suitable related donor for bone marrow transplantation in extended families [J].
Schipper, RF ;
DAmaro, J ;
Oudshoorn, M .
BLOOD, 1996, 87 (02) :800-804
[8]   Distinct tumour necrosis factor α, interferon γ, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis [J].
Spriewald, BM ;
Witzke, O ;
Wassmuth, R ;
Wenzel, RR ;
Arnold, ML ;
Philipp, T ;
Kalden, JR .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) :457-461
[9]  
WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x